4.4 Article

A framework to facilitate consistent characterization of read across uncertainty

期刊

REGULATORY TOXICOLOGY AND PHARMACOLOGY
卷 68, 期 3, 页码 353-362

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yrtph.2014.01.004

关键词

Structural-similarity; Chemical analogue identification; Chemical grouping; Structure activity relationship (SAR); Read across; Uncertainty; Risk assessment

向作者/读者索取更多资源

A process for evaluating analogues for use in structure activity relationship (SAR) assessments was previously published (Wu et al., 2010) and tested using a series of case studies (Blackburn et al., 2011). SAR-based read across approaches continue to be broadly used to address toxicological data gaps. The potential additional uncertainty introduced into risk assessments as a result of application of read across approaches to fill data gaps has been widely discussed (OECD, 2007; ECETOC, 2012; Patlewicz et al., 2013), but to date a systematic framework to guide the characterization of uncertainty in read across assessments has not been proposed. The current manuscript presents both a systematic framework to describe potential areas of additional uncertainty that may arise in read across (evaluated based on the number and suitability of analogues contributing data, severity of the critical effect, and effects and potency concordance), as well as a questionnaire for evaluating and documenting consideration of these potential additional sources of uncertainty by risk assessors. Application of this framework represents a next step in standardizing the read across process, both by providing a means to transparently assign a level of uncertainty to a SAR-based read across assessment and by facilitating consistency in read across conclusions drawn by different risk assessors. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
Article Medicine, Legal

New supporting data to guide the use of evident toxicity in acute oral toxicity studies (OECD TG 420)

Fiona Sewell, Ian Ragan, Graham Horgan, David Andrew, Thomas Holmes, Irene Manou, Boris P. Mueller, Tim Rowan, Barbara G. Schmitt, Marco Corvaro

Summary: There are currently three test guidelines for acute oral toxicity studies, but the subjectivity of one guideline may be hindering its wider use. In order to address this, the NC3Rs and EPAA collaborated to analyze historical data and provide recommendations on the recognition of 'evident toxicity'.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)

Article Medicine, Legal

The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls

Michael DeVito, Bas Bokkers, Majorie B. M. van Duursen, Karin van Ede, Mark Feeley, Elsa Antunes Fernandes Gaspar, Laurie Haws, Sean Kennedy, Richard E. Peterson, Ron Hoogenboom, Keiko Nohara, Kim Petersen, Cynthia Rider, Martin Rose, Stephen Safe, Dieter Schrenk, Matthew W. Wheeler, Daniele S. Wikoff, Bin Zhao, Martin van den Berg

Summary: In October 2022, the World Health Organization reevaluated the toxic equivalency factors (TEFs) for chlorinated dioxin-like compounds in a panel convened in Lisbon. This effort utilized an updated database, Bayesian dose response modeling, and meta-analysis to derive Best-Estimate TEFs. Applying these new TEFs may result in lower total toxic equivalents for dioxin-like chemicals.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)